BACKGROUND: Many children stand to benefit from being asthma-free for life with primary (i.e., prenatally started) prevention addressing one environmental exposure in a unifaceted (UF) approach or at least two in a multifaceted (MF) approach. We assessed the cost-effectiveness of primary prevention programmes for Dutch children in a decision-analytic framework. METHODS: A decision-analytic tree model analysing healthcare costs and asthma cases prevented was developed to compare usual care (UC) with two UF and three MF programmes on the primary prevention of asthma amongst children. Programmes were evaluated through incremental cost-effectiveness ratios and net monetary benefits. Decision and parameter uncertainty were subjected to value-of-information analyses. RESULTS: The current UC and one of three MF programmes dominated the other alternatives. The MF programme was more costly but also more effective than UC at an incremental cost-effectiveness ratio of <euro>8,209.20/additional asthma case prevented. The value of perfect information to reduce uncertainty was <euro>291.6M at its lowest. Most of the uncertainty in the cost-effectiveness threshold was attributable to the probability and cost estimates for low-risk children. CONCLUSION: This study supports the feasibility of a structured programme that simultaneously addresses exposure to house dust mites, pet dander, environmental tobacco, and breast-feeding as a cost-effective alternative to UC in the primary prevention of asthma amongst children.
BACKGROUND: Many children stand to benefit from being asthma-free for life with primary (i.e., prenatally started) prevention addressing one environmental exposure in a unifaceted (UF) approach or at least two in a multifaceted (MF) approach. We assessed the cost-effectiveness of primary prevention programmes for Dutch children in a decision-analytic framework. METHODS: A decision-analytic tree model analysing healthcare costs and asthma cases prevented was developed to compare usual care (UC) with two UF and three MF programmes on the primary prevention of asthma amongst children. Programmes were evaluated through incremental cost-effectiveness ratios and net monetary benefits. Decision and parameter uncertainty were subjected to value-of-information analyses. RESULTS: The current UC and one of three MF programmes dominated the other alternatives. The MF programme was more costly but also more effective than UC at an incremental cost-effectiveness ratio of <euro>8,209.20/additional asthma case prevented. The value of perfect information to reduce uncertainty was <euro>291.6M at its lowest. Most of the uncertainty in the cost-effectiveness threshold was attributable to the probability and cost estimates for low-risk children. CONCLUSION: This study supports the feasibility of a structured programme that simultaneously addresses exposure to house dust mites, pet dander, environmental tobacco, and breast-feeding as a cost-effective alternative to UC in the primary prevention of asthma amongst children.
Authors: Guy B Marks; Seema Mihrshahi; Andrew S Kemp; Euan R Tovey; Karen Webb; Catarina Almqvist; Rosario D Ampon; Daniel Crisafulli; Elena G Belousova; Craig M Mellis; Jennifer K Peat; Stephen R Leeder Journal: J Allergy Clin Immunol Date: 2006-05-30 Impact factor: 10.793
Authors: Sandra Kuiper; Tanja Maas; Constant P van Schayck; Jean W M Muris; Huub J A M Schönberger; Edward Dompeling; Barbara Gijsbers; Chris van Weel; J André Knottnerus Journal: Pediatr Allergy Immunol Date: 2005-06 Impact factor: 6.377
Authors: Sandra Kuiper; Jean W M Muris; Edward Dompeling; Arnold D M Kester; Geertjan Wesseling; J André Knottnerus; Constant P van Schayck Journal: J Allergy Clin Immunol Date: 2007-05-10 Impact factor: 10.793
Authors: Emma Gutiérrez de Mesa; Ignacio Hidalgo; Panayotis Christidis; Juan Carlos Ciscar; Eva Vegas; Dolores Ibarreta Journal: Mol Diagn Ther Date: 2007 Impact factor: 4.074
Authors: G Feljandro P Ramos; Sandra Kuiper; Edward Dompeling; Antoinette D I van Asselt; Wim J C de Grauw; J André Knottnerus; Onno C P van Schayck; Tjard R J Schermer; Johan L Severens Journal: BMC Med Res Methodol Date: 2011-11-09 Impact factor: 4.615
Authors: Amin Adibi; Stuart E Turvey; Tae Yoon Lee; Malcolm R Sears; Allen B Becker; Piush J Mandhane; Theo J Moraes; Padmaja Subbarao; Mohsen Sadatsafavi Journal: BMJ Open Respir Res Date: 2021-11
Authors: Stephen T Holgate; Sally Wenzel; Dirkje S Postma; Scott T Weiss; Harald Renz; Peter D Sly Journal: Nat Rev Dis Primers Date: 2015-09-10 Impact factor: 52.329